skip to main content

H.R. 1635 (114th): Charlotte’s Web Medical Access Act of 2015

We don’t have a summary available yet.

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress, and was published on Mar 25, 2015.

Charlotte's Web Medical Access Act of 2015

Amends the Controlled Substances Act (CSA) to exclude cannabidiol and cannabidiol-rich plants: (1) from the definition of "marihuana," and (2) from treatment as a controlled substance under such Act. Defines: (1) "cannabidiol-rich plant" to mean the plant Cannabis sativa L. and any part of such plant with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis; and (2) "cannabidiol" to mean the substance cannabidiol, as derived from a cannabidiol-rich plant.

Exempts cannabidiol or cannabidiol-rich plants from the Federal Food, Drug, and Cosmetic Act.

Declares that nothing in this Act shall restrict any activities related to the use, production, or distribution of marihuana in a state in which such activities are legal under state law.

Terminates this Act three years after its enactment.